WPD-101

N/A

Report date: 2024/04/09 14:45:24

Base Information

Drug NameWPD-101
Drug Alias NameWPD101WPD-101WPD101aWPD101b
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinBiologics > Protein drugs > Toxin
Mechanisms of ActionProtein synthesis inhibitorsInterleukin-13 receptor subunit alpha-2 modulators
TargetsInterleukin-13 receptor subunit alpha-2
Therapy Area/IndicationsGlioblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryPoland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesWake Forest University School Of Medicine
China Registration ClassN/A

Develop Information

Active CompaniesWPD Pharmaceuticals Sp zoo
Inactive CompaniesN/A
Active IndicationsGlioblastoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A